The use of recombinant gamma interferon associated with pentavalent antimony in therapy for visceral leishmaniasis.
Badaro
R
R
D000965:Antimony / Q000627:therapeutic use*; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D007898:Leishmaniasis, Visceral / Q000188:drug therapy / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D007371:Interferon-gamma; D000965:Antimony